CIPROBAY TABLET 250MG

Manufacturer
BAYER HEALTHCARE MANUFACTURING S.R.L(ITALY)

Registraction Number
MAL19890115AZ
 

Content

• Active Ingredient: Ciprofloxacin 250 mg (as hydrochloride)

• Severe and/or complicated infections caused by ciprofloxacin-sensitive bacteria where other antimicrobials, approved for a similar indication and to which the causative bacteria are sensitive, were considered not to be an appropriate treatment option, have failed, are contraindicated, or not tolerated.
• Infections of the respiratory tract: Pneumonias caused by Klebsiella, Enterobacter, Proteus, E. coli, Pseudomonas, Haemophilus, Moraxella catarrhalis, Legionella, and Staphylococcus.
• Infections of the middle ear (otitis media), paranasal sinuses (sinusitis), especially if caused by Gram-negative organisms including Pseudomonas aeruginosa or by staphylococci.
• Infections of the eyes.
• Infections of the kidneys and/or the efferent urinary tract.
• Infections of the genital organs, including adnexitis, gonorrhea, prostatitis, and excluding vaginal infections.
• Infections of the abdominal cavity (e.g., gastrointestinal tract or biliary tract infections, peritonitis).
• Infections of the skin and soft tissue.
• Infections of the bones and joints.
• Sepsis.
• Prophylaxis in patients whose immune system has been weakened (e.g., patients on immunosuppressants or with neutropenia).

• Dosage: The dosage is determined by the indication, severity, and site of the infection, the susceptibility of the causative organism(s), and the patient's renal function. For adults, the typical dose is 250 mg twice daily.
• Administration: Take CIPROBAY with or without food. Swallow the tablet whole with water.
• Precautions: Inform your doctor if you have any allergies, liver or kidney problems, or if you are pregnant or planning to become pregnant. Regular monitoring of blood counts and liver function is necessary during treatment.
• Storage: Store at room temperature, away from moisture and heat.